Similar articles

• Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma.

  Willey RF, Godden DJ, Carmichael J, Preston P, Frame M, Crompton GK. Willey RF, et al. Br J Dis Chest. 1982 Jan;76(1):61-8. Br J Dis Chest. 1982. PMID: 7037035 Clinical Trial.
• Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma.

  Ebden P, Jenkins A, Houston G, Davies BH. Ebden P, et al. Thorax. 1986 Nov;41(11):869-74. doi: 10.1136/thx.41.11.869. Thorax. 1986. PMID: 3547757 Free PMC article. Clinical Trial.
• Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler.

  Field HV, Jenkinson PM, Frame MH, Warner JO. Field HV, et al. Arch Dis Child. 1982 Nov;57(11):864-6. doi: 10.1136/adc.57.11.864. Arch Dis Child. 1982. PMID: 6756319 Free PMC article. Clinical Trial.
• Inhaled glucocorticoids: new developments relevant to updating of the asthma management guidelines.

  Barnes PJ. Barnes PJ. Respir Med. 1996 Aug;90(7):379-84. doi: 10.1016/s0954-6111(96)90108-0. Respir Med. 1996. PMID: 8796227 Review. No abstract available.
• [Beclomethasone dipropionate, budesonide and flunisolide in the treatment of bronchial asthma (a review of the literature and the authors' own research)].

  Kakhnovskiĭ IM, Solomatin AS. Kakhnovskiĭ IM, et al. Ter Arkh. 1995;67(3):34-8. Ter Arkh. 1995. PMID: 7770801 Review. Russian.